市場調査レポート

商品コード

1514895

マラリアと鎌状赤血球症治療市場：疾患別、薬剤タイプ別、投与経路別、国別、地域別：産業分析、市場規模、市場シェア、2024年～2032年予測

Malaria and Sickle Cell Disease Treatment Market, By Disease, By Drug Type, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: 2024年06月11日
発行: AnalystView Market Insights
ページ情報: 英文 388 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 3,250 466,602円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷はできません。

PDF (5 User License)

USD 4,650 667,600円

レポートPDFを同一事業所内の5名までがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Enterprise User License)

USD 5,650 811,170円

レポートPDF & Excelをを企業内すべての方がご利用頂けるライセンスです。PDF & Excel内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDF & Excelの印刷は可能です。印刷したもののご利用はPDF & Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

レポートハイライト

マラリアと鎌状赤血球症治療市場規模は2023年に56億1,136万米ドルとなり、2024年から2032年にかけてCAGR 25.9%で拡大

マラリアと鎌状赤血球症治療市場-市場力学

高い有病率の中でのマラリアと鎌状赤血球症の治療の進歩

マラリアと鎌状赤血球症治療における進歩は、高い有病率の中で、これらの疾患によってもたらされる世界の健康上の重大な負担に対処するために極めて重要です。例えば、世界保健機関（WHO）によると、マラリアは世界で年間2億人以上が罹患しています。鎌状赤血球症連合によると、鎌状赤血球症（SCD）を患う子どもは世界で年間30万人いると推定されています。この数は2050年までに40万人に増加すると予想されています。これに対し、国立衛生研究所（NIH）やビル＆メリンダ・ゲイツ財団などの組織は、革新的な治療法や予防戦略の開発を目的とした研究開発に投資しています。最近の画期的な出来事としては、タフェノキンのような新しい抗マラリア薬の承認や、鎌状赤血球症に対する有望な遺伝子編集療法の出現などがあり、ヘルスケアの進歩が世界中の罹患者の負担を軽減する可能性を示しています。

マラリアと鎌状赤血球症治療市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約25.9%のCAGRで毎年成長すると予測されています。

疾患別では、鎌状赤血球症が2023年に最大の市場シェアを示すと予測されます。

薬剤タイプ別では、2023年に抗マラリア薬が主要なタイプでした。

地域別では、アジア太平洋地域が2023年の売上高でトップでした。

マラリアと鎌状赤血球症治療市場-セグメンテーション分析：

世界のマラリアと鎌状赤血球症治療市場は、疾患、薬剤タイプ、投与経路、地域に基づいて細分化されます。

マラリアと鎌状赤血球症治療市場は、疾患によって2つのカテゴリーに分けられる：マラリアと鎌状赤血球症です。マラリアは、患者数の増加と耐性菌対策として即効性のある薬剤を優先し、患者数の多い地域に重点を置いています。一方、鎌状赤血球症は、慢性症状の長期的な管理と患者のQOLの向上を目標としています。

市場は薬剤の種類によって3つのカテゴリーに分けられる：抗マラリア薬、疼痛管理薬、疾患修飾療法です。抗マラリア薬は、寄生虫そのものを標的とするもので、圧倒的なシェアを占めています。疼痛管理薬は鎌状赤血球症の主要な症状に対処します。最も有望な分野は疾患修飾療法で、疾患の進行を遅らせ、長期的な転帰を改善する可能性があります。

マラリアと鎌状赤血球症治療市場-地理的洞察

マラリアと鎌状赤血球症治療市場は多様なパターンを示しており、特にサハラ以南のアフリカと東南アジアの一部など、これらの疾患の影響を大きく受けている地域に大きな活動が集中しています。マラリアが蔓延し、鎌状赤血球症の有病率が高いアフリカでは、Roll Back Malaria Partnership（マラリア・ロールバック・パートナーシップ）や国家マラリア対策プログラムのような取り組みが、治療や介入に対する需要を促進しています。さらに、ヘルスケアへのアクセスを改善し、医療インフラを強化する取り組みが、これらの地域の市場成長に寄与しています。東南アジアでは、インドやインドネシアのような国々がマラリアの深刻な問題に取り組んでおり、インドやナイジェリアのような人口の多い国では鎌状赤血球症が依然として懸念されています。これらの地域は、マラリアと鎌状赤血球症治療薬の主要市場であり、これらの疾患と闘い、ヘルスケアへのアクセスと提供を改善するための継続的な取り組みが市場拡大の原動力となっています。

マラリアと鎌状赤血球症治療市場-競合情勢：

マラリアと鎌状赤血球症治療市場は、ファイザー、ノバルティス、サノフィのような製薬大手の戦場です。これらの企業は、新薬の上市（例：ノバルティスの1日1回投与のマラリア治療薬）、有望企業の買収（例：ファイザーによる鎌状赤血球治療のリーダー、世界・ブラッド・セラピューティクスの買収）、次世代ソリューションのための研究開発への多額の投資などの戦略により、常に優位に立つために革新を続けています。このような熾烈な競争は、患者にとっては朗報です。なぜなら、改善された治療薬、より容易な治療法、そして願わくば、両疾患におけるアンメット・ニーズを解決する画期的な治療法が次々と生み出されるからです。

イントロダクション
北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
アジア太平洋地域
- 概要
- アジア太平洋地域の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
中東およびアフリカ
- 概要
- 中東・アフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他

第11章主要ベンダー分析- マラリアと鎌状赤血球症治療業界

競争ダッシュボード
企業プロファイル
- AbbVie Inc.
- Alexion Pharmaceuticals, Inc.（acquired by AstraZeneca）
- Bluebird bio Inc.
- Celgene Corporation（acquired by Bristol Myers Squibb）
- Emmaus Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Johnson &Johnson
- MacroGenics, Inc.
- Merck &Co., Inc.
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Sobi
- Vertex Pharmaceuticals Incorporated
- Others

第12章アナリストの全方位展望

図表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Malaria and Sickle Cell Disease Treatment Market: Disease Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Disease
TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Disease 2019-2032 (USD Million)
TABLE Malaria and Sickle Cell Disease Treatment Market: Drug Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Drug Type
TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Drug Type 2019-2032 (USD Million)
TABLE Malaria and Sickle Cell Disease Treatment Market: Route of Administration Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Route of Administration
TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Route of Administration 2019-2032 (USD Million)
TABLE Malaria and Sickle Cell Disease Treatment Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Region 2019-2032 (USD Million)
TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)

List of Figures

FIGURE Malaria and Sickle Cell Disease Treatment Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2023
FIGURE Disease segment market share analysis, 2023 & 2032
FIGURE Disease segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Drug Type segment market share analysis, 2023 & 2032
FIGURE Drug Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Route of Administration segment market share analysis, 2023 & 2032
FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2023 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
FIGURE Europe Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
FIGURE Asia Pacific Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
FIGURE North America market share analysis by country, 2023
FIGURE U.S. Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
FIGURE Germany Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
FIGURE India Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Philippines Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
FIGURE Brazil Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
FIGURE Saudi Arabia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)

Product Code: ANV3025

REPORT HIGHLIGHT

Malaria and Sickle Cell Disease Treatment Market size was valued at USD 5,611.36 million in 2023, expanding at a CAGR of 25.9% from 2024 to 2032.

The Malaria and Sickle Cell Disease Treatment Market refers to the industry segment focused on the development and provision of therapies and interventions for combating malaria and managing sickle cell disease. The persistent global burden of malaria, particularly in tropical and subtropical regions, driving investments in research and development for innovative treatments and preventive measures. Additionally, the growing prevalence of sickle cell disease, especially in regions with high malaria transmission rates, further fuels market growth, prompting efforts to enhance disease management and develop curative therapies. However, restraints include the challenge of drug resistance in malaria treatment and the complexity of sickle cell disease management, compounded by limited access to healthcare in resource-constrained settings. Nevertheless, opportunities abound with advancements in precision medicine and gene therapy, promising novel approaches for personalized treatment and potential cures, thereby driving innovation and market expansion in the malaria and sickle cell disease treatment landscape.

Malaria and Sickle Cell Disease Treatment Market- Market Dynamics

Advancements in Treating Malaria and Sickle Cell Disease Amidst High Prevalence

Advancements in treating malaria and sickle cell disease amidst high prevalence are crucial for addressing the significant global health burden posed by these conditions. For instance, according to the World Health Organization (WHO), malaria affects over 200 million people worldwide annually. According to the Sickle Cell Disease Coalition, an estimated 300,000 children are born annually with sickle cell disease (SCD) worldwide. This number is expected to increase to 400,000 by 2050. In response, organizations like the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation are investing in research initiatives aimed at developing innovative treatments and preventive strategies. Recent breakthroughs include the approval of new antimalarial drugs like tafenoquine and the emergence of promising gene-editing therapies for sickle cell disease, underscoring the potential of advancements in healthcare to alleviate the burden of these diseases on affected populations worldwide.

Malaria and Sickle Cell Disease Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 25.9% over the forecast period (2024-2032)

Based on Disease segmentation, Sickle Cell Disease was predicted to show maximum market share in the year 2023

Based on Drug Type segmentation, Antimalarial Drugs was the leading type in 2023

Based on region, Asia Pacific was the leading revenue generator in 2023

Malaria and Sickle Cell Disease Treatment Market- Segmentation Analysis:

The Global Malaria and Sickle Cell Disease Treatment Market is segmented based on Disease, Drug Type, Route of Administration, and Region.

The market is divided into two categories based on Disease: Malaria and Sickle cell disease. Malaria prioritizes fast-acting drugs to combat rising cases and resistance, focusing on high-burden regions. Conversely, the sickle cell segment targets long-term management of chronic symptoms and improving patients' quality of life.

The market is divided into three categories based on Drug Type: Antimalarial Drugs, Pain Management Drugs, and Disease-Modifying Therapies. Antimalarial drugs dominate, targeting the parasite itself. Pain management drugs address a key symptom of sickle cell disease. The most promising segment is disease-modifying therapies, offering the potential to slow disease progression and improve long-term outcomes.

Malaria and Sickle Cell Disease Treatment Market- Geographical Insights

The Malaria and Sickle Cell Disease Treatment Market exhibits diverse patterns, with significant activity concentrated in regions disproportionately affected by these diseases, particularly in sub-Saharan Africa and parts of Southeast Asia. In Africa, where malaria is endemic and sickle cell disease prevalence is high, initiatives like the Roll Back Malaria Partnership and national malaria control programs drive demand for treatments and interventions. Additionally, efforts to improve access to healthcare and strengthen healthcare infrastructure contribute to market growth in these regions. In Southeast Asia, countries like India and Indonesia grapple with significant malaria burdens, while sickle cell disease remains a concern in countries with large populations such as India and Nigeria. These regions collectively represent key markets for malaria and sickle cell disease treatments, with opportunities for market expansion driven by ongoing efforts to combat these diseases and improve healthcare access and delivery.

Malaria and Sickle Cell Disease Treatment Market- Competitive Landscape:

The Malaria and Sickle Cell Disease treatment market is a battlefield for pharmaceutical giants like Pfizer, Novartis, and Sanofi. These companies are constantly innovating to stay ahead, with strategies like launching new drugs (e.g., Novartis' once-daily malaria treatment), acquiring promising companies (e.g., Pfizer's acquisition of sickle cell therapy leader Global Blood Therapeutics), and investing heavily in R&D for next-generation solutions. This fierce competition is good news for patients, as it translates into a constant flow of improved medications, easier treatment regimens, and hopefully, breakthroughs that address unmet needs in both diseases.

Recent Developments:

In September 2022, Vertex Pharmaceuticals and CRISPR Therapeutics launched a gene therapy called "exa-cel" for treating sickle cell disease. The treatment involves permanently changing DNA in a patient's blood cells to help the body produce a fetal form of hemoglobin, which is naturally present at birth but switches to an adult form that is defective in people with sickle cell disease.

In December 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)

Bluebird Bio Inc.

Celgene Corporation (acquired by Bristol Myers Squibb)

Emmaus Pharmaceuticals, Inc.

F. Hoffmann-La Roche Ltd

Gilead Sciences, Inc.

GlaxoSmithKline plc

Johnson & Johnson

MacroGenics, Inc.

Merck & Co., Inc.

Novartis International AG

Pfizer Inc.

Sanofi S.A.

Sobi

Vertex Pharmaceuticals Incorporated

Others

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

Malaria
Sickle cell disease

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

Antimalarial Drugs
Pain Management Drugs
Disease-Modifying Therapies
Other

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Oral
Parenteral

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Malaria and Sickle Cell Disease Treatment Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Malaria and Sickle Cell Disease Treatment Market Snippet by Disease
- 2.1.2. Malaria and Sickle Cell Disease Treatment Market Snippet by Drug Type
- 2.1.3. Malaria and Sickle Cell Disease Treatment Market Snippet by Route of Administration
- 2.1.4. Malaria and Sickle Cell Disease Treatment Market Snippet by Country
- 2.1.5. Malaria and Sickle Cell Disease Treatment Market Snippet by Region
2.2. Competitive Insights

3. Malaria and Sickle Cell Disease Treatment Key Market Trends

3.1. Malaria and Sickle Cell Disease Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Malaria and Sickle Cell Disease Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Malaria and Sickle Cell Disease Treatment Market Opportunities
3.4. Malaria and Sickle Cell Disease Treatment Market Future Trends

4. Malaria and Sickle Cell Disease Treatment Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Malaria and Sickle Cell Disease Treatment Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Malaria and Sickle Cell Disease Treatment Market Landscape

6.1. Malaria and Sickle Cell Disease Treatment Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Malaria and Sickle Cell Disease Treatment Market - By Disease

7.1. Overview
- 7.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
- 7.1.2. Malaria
- 7.1.3. Sickle cell disease

8. Malaria and Sickle Cell Disease Treatment Market - By Drug Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
- 8.1.2. Antimalarial Drugs
- 8.1.3. Pain Management Drugs
- 8.1.4. Disease-Modifying Therapies
- 8.1.5. Other

9. Malaria and Sickle Cell Disease Treatment Market - By Route of Administration

9.1. Overview
- 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
- 9.1.2. Oral
- 9.1.3. Parenteral

10. Malaria and Sickle Cell Disease Treatment Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Malaria and Sickle Cell Disease Treatment Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. AbbVie Inc.
- 11.2.2. Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)
- 11.2.3. Bluebird bio Inc.
- 11.2.4. Celgene Corporation (acquired by Bristol Myers Squibb)
- 11.2.5. Emmaus Pharmaceuticals, Inc.
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.7. Gilead Sciences, Inc.
- 11.2.8. GlaxoSmithKline plc
- 11.2.9. Johnson & Johnson
- 11.2.10. MacroGenics, Inc.
- 11.2.11. Merck & Co., Inc.
- 11.2.12. Novartis International AG
- 11.2.13. Pfizer Inc.
- 11.2.14. Sanofi S.A.
- 11.2.15. Sobi
- 11.2.16. Vertex Pharmaceuticals Incorporated
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

マラリアと鎌状赤血球症治療市場：疾患別、薬剤タイプ別、投与経路別、国別、地域別：産業分析、市場規模、市場シェア、2024年～2032年予測

Malaria and Sickle Cell Disease Treatment Market, By Disease, By Drug Type, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

レポートハイライト

マラリアと鎌状赤血球症治療市場-セグメンテーション分析：

マラリアと鎌状赤血球症治療市場-競合情勢：

目次

第1章 マラリアと鎌状赤血球症治療市場概要

第2章 エグゼクティブサマリー

第3章 マラリアと鎌状赤血球症治療の主要市場動向

第4章 マラリアと鎌状赤血球症治療産業研究

第5章 マラリアと鎌状赤血球症治療市場： COVID-19の影響分析

第6章 マラリアと鎌状赤血球症治療市場情勢

第7章 マラリアと鎌状赤血球症治療市場- 疾患別

第8章 マラリアと鎌状赤血球症治療市場- 薬剤タイプ別

第9章 マラリアと鎌状赤血球症治療市場- 投与経路別

第10章 マラリアと鎌状赤血球症治療市場-地域別

第11章 主要ベンダー分析- マラリアと鎌状赤血球症治療業界

第12章 アナリストの全方位展望